A. Hilli

Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia

T. Aittokallio, S. Fernandes, K. Taskén, 2022, bioRxiv.